Trending Now
Kiora Pharmaceuticals Inc (NASDAQ: KPRX) Announces Financial Results For Quarter and...
Kiora Pharmaceuticals Inc (NASDAQ: KPRX) has announced financial results for the quarter and six months ending June 30, 2022, and provided a business update.
CEO...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Aquestive Therapeutics Inc. (NASDAQ:AQST) Reports Revenue Of $8.3 Million In Q3...
Aquestive Therapeutics Inc. (NASDAQ:AQST) has announced its Q3 2020 financial results and provided recent business development updates.
Aquestive posts revenue of $8.3 million
The company reported...
MAKE IT MODERN
LATEST REVIEWS
NeuroBo Pharmaceuticals Inc. (NASDAQ: NRBO) To Continue ANA001 Phase 2/3 Clinical...
NeuroBo Pharmaceuticals Inc. (NASDAQ: NRBO) has announced the review of safety data by an independent Data Monitoring Committee for 36 patients that were treated...
MAKE IT MODERN
PERFORMANCE TRAINING
Alzamend Neuro (ALZN) Could Triple from current levels and here’w why
In a remarkable surge on the stock market today, shares of Alzamend Neuro, Inc. (Nasdaq: ALZN) skyrocketed by more than 300%, following...
Amicus Therapeutics (NASDAQ:FOLD) Commences Rolling BLA For AT-GAA In Treatment Of Late-Onset Pompe Disease
Amicus Therapeutics (NASDAQ:FOLD) has announced that the commencement of the rolling Biologics License Application submission to the US FDA for its experimental two-component therapy,...
Aditxt Inc (NASDAQ: ADTX) Announces that the Group Will Acquire the Assets of AiPharma...
Aditxt Inc (NASDAQ: ADTX), in a statement, announced that the group had inked a binding agreement with AiPharma Global Holdings LLC. As per the...
HOOKIPA Pharma Inc. (OTCMKTS: HOOK) Announce Restatement and Amendment of Partnership and licensing agreement...
HOOKIPA Pharma Inc. (OTCMKTS: HOOK) has announced the signing of a restated and amended partnership and license deal with Gilead to develop proprietary arenaviral...
Amarin Corporation Plc (NASDAQ:AMRN) Reports A Growth Of 34% YoY In Q2 2020 Revenues:...
Amarin Corporation Plc (NASDAQ:AMRN) posted revenues of $135.3 million in Q2 2020. President of Amarin, John F. Thero said Q2 2020 is a challenging...
MAKE IT MODERN
